SERIES A COMMON STOCK PURCHASE WARRANT ENDRA LIFE SCIENCES INC.ENDRA Life Sciences Inc. • May 10th, 2024 • Electromedical & electrotherapeutic apparatus • New York
THIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, including the prior receipt of Shareholder Approval as set forth in Section 3(i) at any time on or after the Shareholder Approval Date (as defined below) (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the five-year anniversary of the Initial Exercise Date, provided that if such date is not a Trading Day, the immediately following Trading Day (the “Termination Date”) but not thereafter, to subscribe for and purchase from ENDRA Life Sciences Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Sectio
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • May 10th, 2024 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus • New York
LOCK-UP AGREEMENTLock-Up Agreement • May 10th, 2024 • ENDRA Life Sciences Inc. • Electromedical & electrotherapeutic apparatus
Re: Placement Agency Agreement, dated as of ___________, 2024 (the “Placement Agency Agreement”), by and between ENDRA Life Sciences Inc. (the “Company”) and Craig-Hallum Capital Group LLC (the “Placement Agent”)
